In addition to the epigenetic heterogeneity, we also observed that the clinical behavior of glioma with FGFR3::TACC3 fusion was also heterogeneous with some patients that had a stable disease in contrast to others. The gene discussed is TACC3; the disease is central nervous system cancer.